An innovative class of anti-inflammatory medication is created by researchers that targets both NLRP1 and NLRP3 inflammasomes.

Published Date: 12 Jul 2023

Numerous new therapeutic options are now available for conditions ranging from cancer to neurological disorders, thanks to a new class of anti-inflammatory drugs.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers find distinct cell receptors with the potential for new treatments.

2.

Breast cancer patients' arms swell less after an effective lymph node transfer.

3.

Telehealth in the pandemic era resulted in fewer therapy interruptions.

4.

Too Many Chest CTs for Incidental Lung Nodules?

5.

Global warming could be driving up women's cancer risk, find researchers


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot